Showing 1 to 1 of 1 results
sante.lefigaro.fr
🌐 75% Global Worthiness


High Cost of Shingles Vaccine in France Sparks Debate
France's decision to include the Shingrix vaccine in its vaccination program for those over 65 is debated due to its high cost (€6 billion over five years) despite high efficacy (79% against shingles, 87% against chronic pain) and the fact that those over 65 account for 72% of hospitalizations relat...
High Cost of Shingles Vaccine in France Sparks Debate
France's decision to include the Shingrix vaccine in its vaccination program for those over 65 is debated due to its high cost (€6 billion over five years) despite high efficacy (79% against shingles, 87% against chronic pain) and the fact that those over 65 account for 72% of hospitalizations relat...
Progress
44% Bias Score
Good Health and Well-being
Showing 1 to 1 of 1 results